Marius Pearson
HEOR and market access are evolving, with big changes in HTA around the corner, acceleration in the use of RWE and increased reactions to cost-containment measures. We are contributing to conversations about how these changes affect value demonstration strategies. At Oxford PharmaGenesis, we are experts in advising on payer strategy, developing payer evidence and supporting payer evaluation. We understand differences in payer evidence needs, and we know how to create compelling value stories for our clients that achieve powerful results.
Read More
Many scientific and medical publications lie behind a paywall. New medical research is increasingly being published as ‘open access’, which makes articles freely available to anyone. This provides major benefits because it gives researchers and members of the public equal access to medical knowledge. It also improves research transparency, which helps to foster public trust.
Read More
More than 150 medical publications professionals gathered in Philadelphia on 28–29 September 2023 for the inaugural ISMPP Academy. Oxford PharmaGenesis was a key event sponsor and we were delighted to give two valuable presentations to help attendees to explore new frontiers in publications. In line with the ISMPP Academy theme ‘PREP! Practical Resources to Elevate […]
Read More
We are thrilled to celebrate five colleagues who have dedicated more than 20 years to Oxford PharmaGenesis! They have helped to deliver everything from traditional medical communications to innovative patient engagement materials, not only serving our clients but also advancing our company mission along the way.
Read More
The publication of clinical study results is key to communicating how well medicines can treat diseases. It is vital that these results are made available as quickly as possible, so it’s important to know what influences the ‘time to publication’ (the time from the end of the study to publication of the results in a […]
Read More
Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media, and more.
Read More
ORCID iDs are digital identity tags for authors of research papers. Authors who sign up to ORCID are given a unique number, which is linked to an online profile where they can add information about where they work and their education, awards and published works. Authors can add their ORCID iD to any research papers […]
Read More
We were honoured on Friday as King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM, presented our HealthScience Communications Consultancy with a 2023 King’s Award at our head office just outside Oxford, UK.
Read More
Oxford PharmaGenesis is proud to have been a finalist for the prestigious 2023 Communiqué Leadership Award for Action on Workforce Diversity and Inclusion. The awards ceremony took place on Thursday 6 July at the Dorchester Hotel, London, UK.
Read More
We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.
Read More